id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2008-D-0525-0001,FDA,FDA-2008-D-0525,Draft Guidance for Industry on New Contrast Imaging Indication Considerations for Devices and Approved Drug and Biological Products; Availability,Notice,NAD-Notice of Availability of Data,2008-10-07T04:00:00Z,2008,10,2008-10-07T04:00:00Z,2009-01-06T04:59:59Z,2024-11-07T21:57:35Z,E8-23712,1,0,090000648073b491
FDA-2008-D-0525-0002,FDA,FDA-2008-D-0525,Guidance for Industry: New Contrast Imaging Indication Considerations for Devices and Approved Drug and Biological Products - Draft Guidance,Other,GDL-Guidance (Supporting and Related Materials),2008-10-07T04:00:00Z,2008,10,,,2024-11-07T21:55:50Z,,1,0,090000648073b807